Oracle rolls out AI agents for clinical trials

Advertisement

Oracle has introduced new AI agents designed to help life sciences organizations monitor clinical trials, identify operational risks and coordinate research activities.

The Oracle Life Sciences AI Agents, according to a Nov. 18 news release, are designed to bring together information from Oracle’s life sciences applications and supported third-party data sources to help clinical research teams make operational decisions.

The agents can monitor study performance, identify potential causes of deviations from key performance indicators and recommend actions consistent with clinical trial protocols, according to Oracle.

The technology focuses on three areas of clinical trial operations: portfolio monitoring, trial planning and trial conduct.

The AI agents are designed to operate with human oversight. Clinical research teams must review recommendations and approve proposed actions before they are carried out.

The agents are available to early adopters. Oracle plans to expand their capabilities to additional areas, including clinical data management, post-trial analytics, trial design and post-market workflows.

The announcement is part of Oracle’s broader efforts to incorporate AI into healthcare and life sciences operations.

Advertisement

Next Up in Innovation

Advertisement